Healthcare & Pharmaceuticals

High Time for European Pharmaceuticals: Changing Medical-Cannabis Regulation by Estia Ryan

Six new countries have announced medical legalization in 2018 alone. This now means 22 countries in the region allow cannabis-derived medicines. The boundaries between legal and illegal drugs are usually quite blurred – and any changes in the regulatory landscape should excite investors. Earlier this summer, Sajid Javid relaxed UK rules concerning cannabis-derived medicines after…

Read More

NHS: How much will Brexit cost us? By Aram Andreasyan

At the most recent National Cancer Research Institute Conference, Nicola Ferguson Sturgeon, the fifth and current First Minister of Scotland and leader of the Scottish National Party, stated that the chances of Brexit having harmful impacts on healthcare services of the UK are very high. Mrs Sturgeon urges the government to “come clean” regarding the…

Read More

Pharma and biotech M&A activity to hit fresh highs in 2018

Hyesung Lim The year 2018 is set to be an M&A heavy one for the pharmaceutical industry, as companies look to boost drug portfolios, offset revenue declines from patent expiries, and compete with innovative rivals. The U.S. tax overhaul and repatriation of overseas cash is expected to inject billions into big pharma, boosting the incentive…

Read More

Flotation of Siemens’ healthcare unit to be the largest German IPO in two decades

Hyesung Lim On Wednesday, the European engineering conglomerate Siemens AG announced its plans to list its diagnostics technology division Healthineers on the Frankfurt stock exchange during the first half of 2018. The partial flotation of this €40bn medical solutions business is anticipated to be the largest public offering in Germany since the €13bn listing of…

Read More

The implications of technology in healthcare

Hyesung Lim With advancements in technology causing far-reaching disruptions across the business landscape, there has been a race among companies in all regions and industry sectors to reap the competitive advantages offered by the latest innovations. Pharmaceutical and healthcare companies have not been an exception to such a pervasive trend. Recent movements show that they…

Read More

Pharma companies are safe from Amazon – but for how long?

Jake Buckley For the past few weeks it has appeared increasingly likely that e-commerce giant Amazon has been preparing for a move into the drug selling business. In the last couple of days, however, Amazon has told regulators it will not ‘ship or sell drugs’ and instead seem set to tackle the simpler market of…

Read More

Integra Acquires J&J Neurosurgery Unit

Pavit Bangur Fresh from its $30 billion acquisition of Actelion, Europe’s biggest biotech company, Johnson & Johnson (J&J), the largest publically traded healthcare company, are on the opposing end. Integra LifeSciences Holdings Corp is looking to acquire J&J’s Codman Neurosurgery unit for $1.045 billion; its intention is to expand its presence outside of the United…

Read More